Nedim Turan

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 12

Top Topics

Sentinel Lymph Node

Prognostic Factors

Metastatic Breast Cancer

Top Venues

Scientific reports

Medicina (Kaunas, Lithuania)

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

This page only lists publications with an associated author ORCID identifier.

Publications

Arif Akyildiz, Melis Gultekin, Ecem Yigit, Ecem Demir, Rashad Ismayilov, Melin Aydan Ahmed, Mustafa Buyukkor, Hasan Cagrı Yıldırım, Nilgun Yıldırım, Gokhan Ucar, Efnan Algin, Ahmet Emin Ozturk, Sinem Akbas, Fatih Selcukbiricik, Seval Orman, Nedim Turan, Mesut Yilmaz, Rumeysa Colak, Esra Ozen Engin, Nargiz Majidova, Ibrahim Vedat Bayoglu, Havva Beyaz, Ozturk Ates, Kamuran Ibıs, Sefika Arzu Ergen, Sezin Yuce Sari, Yilmaz Tezcan, Ferah Yildiz, Zafer Arik
Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (9) (2024)
Oguzcan Kinikoglu, Hatice Odabaş, Yunus Emre Altıntaş, Anıl Yıldız, Burçin Çakan, Goncagül Akdağ, Sedat Yildirim, Hamit Bal, Tuğba Kaya, Salih Tünbekici, Deniz Işık, Tuğba Başoğlu, Mahmut Emre Yildirim, Nedim Turan
Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer. Medicina (Kaunas, Lithuania) 60 (6) (2024)
Arif Akyildiz, Melis Gultekin, Ecem Yigit, Ecem Demir, Rashad Ismayilov, Melin Aydan Ahmed, Mustafa Buyukkor, Hasan Cagrı Yıldırım, Nilgun Yıldırım, Gokhan Ucar, Efnan Algin, Ahmet Emin Ozturk, Sinem Akbas, Fatih Selcukbiricik, Seval Orman, Nedim Turan, Mesut Yilmaz, Rumeysa Colak, Esra Ozen Engin, Nargiz Majidova, Ibrahim Vedat Bayoglu, Havva Beyaz, Ozturk Ates, Kamuran Ibıs, Sefika Arzu Ergen, Sezin Yuce Sari, Yilmaz Tezcan, Ferah Yildiz, Zafer Arik
Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Eyyüp Cavdar, Oguzcan Kinikoglu, Sila Oksuz, Hacer Sahika Yildiz, Aysun Kucukoz Uzun, Deniz Işık, Heves Surmeli, Tugba Basoglu Tuylu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients. Cancers 16 (14) (2024)
Oguzcan Kinikoglu, Hatice Odabaş, Yunus Emre Altıntaş, Anıl Yıldız, Burçin Çakan, Goncagül Akdağ, Sedat Yildirim, Hamit Bal, Tuğba Kaya, Salih Tünbekici, Deniz Işık, Tuğba Başoğlu, Mahmut Emre Yildirim, Nedim Turan
Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer. Medicina (Kaunas, Lithuania) 60 (6) (2024)
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Eyyüp Cavdar, Oguzcan Kinikoglu, Sila Oksuz, Hacer Sahika Yildiz, Aysun Kucukoz Uzun, Deniz Işık, Heves Surmeli, Tugba Basoglu Tuylu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients. Cancers 16 (14) (2024)
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Zeynep Yüksel Yasar, Hamit Bal, Oguzcan Kinikoglu, Sila Oksuz, Ugur Ozkerim, Salih Tunbekici, Hacer Sahika Yildiz, Özkan Alan, Sermin Coban Kokten, Deniz Işık, Heves Surmeli, Tugba Basoglu Tuylu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy. Scientific reports 14 (1) (2024)
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Zeynep Yüksel Yasar, Hamit Bal, Oguzcan Kinikoglu, Sila Oksuz, Ugur Ozkerim, Salih Tunbekici, Hacer Sahika Yildiz, Özkan Alan, Sermin Coban Kokten, Deniz Işık, Heves Surmeli, Tugba Basoglu Tuylu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy. Scientific reports 14 (1) (2024)
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Zeynep Yüksel Yasar, Hamit Bal, Oguzcan Kinikoglu, Sila Oksuz, Ugur Ozkerim, Salih Tunbekici, Hacer Sahika Yildiz, Özkan Alan, Sermin Coban Kokten, Deniz Işık, Heves Surmeli, Tugba Basoglu Tuylu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy. Scientific reports 14 (1) (2024)
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Eyyüp Cavdar, Oguzcan Kinikoglu, Sila Oksuz, Hacer Sahika Yildiz, Aysun Kucukoz Uzun, Deniz Işık, Heves Surmeli, Tugba Basoglu Tuylu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients. Cancers 16 (14) (2024)
Goncagul Akdag, Deniz Işık, Akif Dogan, Sedat Yildirim, Oguzcan Kinikoglu, Alper Topal, Sila Oksuz, Ezgi Turkoglu, Heves Surmeli, Tugba Basoglu, Ozlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
Does Adjuvant Chemotherapy Benefit Patients with T4 N0 Colon Cancer? Medicina (Kaunas, Lithuania) 60 (8) (2024)
Goncagul Akdag, Özkan Alan, Akif Dogan, Zeynep Yüksel Yasar, Sedat Yildirim, Oguzcan Kinikoglu, Emre Kudu, Heves Surmeli, Hatice Odabaş, Mahmut Emre Yildirim, Nedim Turan
Outcomes of surveillance versus adjuvant treatment for patients with stage-I seminoma: a single-center experience. World journal of urology (2023)